Alimera Sciences Incis A Global Pharmaceutical Company Based In Alpharettageorgiaspecializing In Retinal Healthfounded In 2003 And Listed On Nasdaq Under The Ticker Alimthe Company Is Dedicated To Developing And Commercializing Innovative Ophthalmic Treatments Aimed At Preserving Visionalimera Operates Internationallywith Products Available In The U S Europeand Other Markets The Company S Key Products Include Iluviena A Sustained Release Implant That Treats Diabetic Macular Edema And Chronic Non Infectious Uveitis Affecting The Posterior Segmentand Yutiqa Which Also Targets Chronic Non Infectious Uveitisalimera Emphasizes Collaboration With Healthcare Providersoffering Education On Retinal Disease Management And Long Term Treatment Solutionstheir Guiding Principles Focus On Accountability And Teamworkreflecting A Commitment To Innovation In Retinal Health
No conferences found for this company.
| Company Name | Alimera Sciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
